PDE3B Blocking Peptide for STJ502607 peptide (STJ505764)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 260-310 on rat PDE3B protein. Selective for only PDE3B variant
General Information
| Short Description | PDE3B Blocking Peptide for STJ502607 is synthetically produced from the 260-310 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 260-310 on rat PDE3B protein. Selective for only PDE3B variant |
| Immunogen Region | 260-310 |
| Specificity | This blocking peptide is recommended for use in combination with PDE3B antibody, STJ502607 |
Additional Info
| Background | Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. May play a role in fat metabolism. Regulates cAMP binding of RAPGEF3. |
Information sourced from Uniprot.org